Home World Business Apollo Health expects partner Sanofi to help expand diabetes care business

Apollo Health expects partner Sanofi to help expand diabetes care business

SHARE

The company leans on Sanofi for its large insulin portfolio and fundamental research in diabetes

Gireesh Babu  |  Chennai  May 2, 2017 Last Updated at 01:04 IST

Apollo Health and Lifestyle, the subsidiary of Apollo Hospitals Enterprise Ltd, has said that the synergy with the Group in its business would help it to grow its presence in India and abroad. The clinical practice model that has developed could be expanded across the country and also be scaled up internationally, and this is where Sanofi’s exerience would help, said Sangita Reddy, joint managing director of AHEL.

“As we look to scale up — and possibly scale internationally — with this model, which we believe that it is better than most of the models available in the market, I think will be a very good partner,” Reddy said in an interaction with analysts.

The company has been looking for a partner who has a deep understanding of diabetes. fits the bill as it is a leading company, with a large portfolio and a lot of fundamental research in the diabetes space. Apollo Health feels would make a strong strategic partner who help chart the future course of diabetes care, said Neeraj Garg, chief executive officer of AHLL.

“They have a strong field force in India that covers a large number of diabetologists. As we look at scaling up this network, we need to leverage their doctor relationships and get access to doctors in many more towns than we currently have,” he added.

Sanofi-Synthelabo India, part of the Group, invested about Rs 90 crore in 2015 and holds 20 per cent of Apollo Sugar Clinic, the business of the Apollo Hospitals Group.

has currently 38 diabetic care centres, three of which are advanced and 35 are primary centres. In FY17, it reported around 1,22,000 consultations with 90 doctors and 27 dieticians. It has posted a revenue of Rs 27.6 crore during FY17 compared to Rs 18.6 crore during the previous fiscal year.

The company is planning to touch a million diabetic lives by 2020 and grow the network to 80-100 centres over the next five years. Plans are to expand operations to non-Apollo network centres as well. The company said it would also look at developing new revenue streams leveraging clinical data and product sales.

Apollo Health expects partner Sanofi to help expand diabetes care business

The company leans on Sanofi for its large insulin portfolio and fundamental research in diabetes

Apollo Health and Lifestyle, the subsidiary of Apollo Hospitals Enterprise Ltd, has said that the the synergy with Sanofi Group in its diabetes care business would help it to grow its presence in India and abroad. The clinical practice model Apollo Sugar Clinics has developed could be expanded across the country and also be scaled up internationally, during when Sanofi’s exerience would help it, said Sangita Reddy, joint managing director of AHEL. “As we look to scale and possibly scale internationally with this model, which we believe that it is better most of the models available in the market, I think Sanofi is a very good partner,” told Reddy in an interaction with analysts.The company was looking for a partner who had deep understanding of diabetes and Sanofi is one of the leading companies with a large insulin portfolio and with a lot of fundamental research they do in the diabetes space. The company felt that they were a strong strategic partner who help chart out future … Apollo Health and Lifestyle, the subsidiary of Apollo Hospitals Enterprise Ltd, has said that the synergy with the Group in its business would help it to grow its presence in India and abroad. The clinical practice model that has developed could be expanded across the country and also be scaled up internationally, and this is where Sanofi’s exerience would help, said Sangita Reddy, joint managing director of AHEL.

“As we look to scale up — and possibly scale internationally — with this model, which we believe that it is better than most of the models available in the market, I think will be a very good partner,” Reddy said in an interaction with analysts.

The company has been looking for a partner who has a deep understanding of diabetes. fits the bill as it is a leading company, with a large portfolio and a lot of fundamental research in the diabetes space. Apollo Health feels would make a strong strategic partner who help chart the future course of diabetes care, said Neeraj Garg, chief executive officer of AHLL.

“They have a strong field force in India that covers a large number of diabetologists. As we look at scaling up this network, we need to leverage their doctor relationships and get access to doctors in many more towns than we currently have,” he added.

Sanofi-Synthelabo India, part of the Group, invested about Rs 90 crore in 2015 and holds 20 per cent of Apollo Sugar Clinic, the business of the Apollo Hospitals Group.

has currently 38 diabetic care centres, three of which are advanced and 35 are primary centres. In FY17, it reported around 1,22,000 consultations with 90 doctors and 27 dieticians. It has posted a revenue of Rs 27.6 crore during FY17 compared to Rs 18.6 crore during the previous fiscal year.

The company is planning to touch a million diabetic lives by 2020 and grow the network to 80-100 centres over the next five years. Plans are to expand operations to non-Apollo network centres as well. The company said it would also look at developing new revenue streams leveraging clinical data and product sales.

image

Gireesh Babu

Business Standard

http://bsmedia.business-standard.com/_media/bs/wap/images/bs_logo_amp.png 177 22

LEAVE A REPLY

Please enter your comment!
Please enter your name here